1 / 1

Biotech Venture Capital Investment Opportunities

According to recent research, emerging biotech companies account for nearly 80 percent of the drug industry, meaning small firms are the major motivating force behind developing creative new therapies.

agronomicsltd
Download Presentation

Biotech Venture Capital Investment Opportunities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biotech Venture Capital: Investment Opportunities The investment world is quickly evolving. These days, people in the US are allowed to invest in small businesses and start-ups owing to the JOBS act. You can easily diversify the portfolio and invest in private firms that range from video games to local breweries to real estate and fitness products. Also, you can invest in biotech venture capital and healthcare firms that were the exclusive field of venture capitalists! New therapies According to recent research, emerging biotech companies account for nearly 80 percent of the drug industry, meaning small firms are the major motivating force behind developing creative new therapies. The recent pandemic is a good example of this. Small biotech firms helped develop the first two COVID-19 vaccines in America. With major trends like an increase in life expectancy, an ageing population and a load of chronic diseases like diabetes and obesity, the chances of developing new therapies have never been better. Good returns with risk While you invest in early-stage small biotech venture capital companies and startups, it will offer you the potential to produce huge financial returns, but just like any other investment they carry risk and early-stage investing nature makes them even riskier. In order to produce financial returns, firms will require to demonstrate that their technology and science are sound enough and can be authenticated; in preclinical studies and in medical trials. Solid evidence that therapy or procedure can benefit people is not an assurance that the studies will back it up; biology is always innately unpredictable. Moreover, healthcare includes a variety of sub-verticals like medtech, biotech, diagnostics and such, each working in a regulated environment with unique pathways to endorsement and each with unique reimbursement frameworks. Verdict Professional investors have learned things the hard way in the past. Just since a product is endorsed by the FDA it doesn’t mean that it will get reimbursement or ample enough reimbursement to develop a sustainable business out of it. Therefore, when seeking to invest in biotech venture capital, it is always best to take a look at the patient and market demands!

More Related